Hillsdale Investment Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,085
| Closed | -$6.21M | – | 671 |
|
|
2024
Q2 | $6.21M | Sell |
15,085
-565
| -4% | -$233K | 0.49% | 38 |
|
|
2024
Q1 | $6.32M | Sell |
15,650
-3,530
| -18% | -$1.43M | 0.5% | 35 |
|
|
2023
Q4 | $5.88M | Sell |
19,180
-620
| -3% | -$190K | 0.48% | 35 |
|
|
2023
Q3 | $4.79M | Sell |
19,800
-200
| -1% | -$48.4K | 0.44% | 57 |
|
|
2023
Q2 | $4.8M | Sell |
20,000
-5,800
| -22% | -$1.39M | 0.44% | 64 |
|
|
2023
Q1 | $4.85M | Buy |
25,800
+50
| +0.2% | +$9.4K | 0.42% | 82 |
|
|
2022
Q4 | $5.47M | Buy |
25,750
+100
| +0.4% | +$21.2K | 0.46% | 55 |
|
|
2022
Q3 | $4.03M | Hold |
25,650
| – | – | 0.36% | 106 |
|
|
2022
Q2 | $3.84M | Sell |
25,650
-100
| -0.4% | -$15K | 0.31% | 124 |
|
|
2022
Q1 | $4.21M | Sell |
25,750
-5,800
| -18% | -$949K | 0.27% | 130 |
|
|
2021
Q4 | $6.87M | Buy |
31,550
+350
| +1% | +$76.2K | 0.46% | 51 |
|
|
2021
Q3 | $5.91M | Sell |
31,200
-800
| -3% | -$151K | 0.46% | 52 |
|
|
2021
Q2 | $5.65M | Sell |
32,000
-700
| -2% | -$124K | 0.45% | 52 |
|
|
2021
Q1 | $5.37M | Buy |
32,700
+24,800
| +314% | +$4.07M | 0.45% | 62 |
|
|
2020
Q4 | $1.1M | Buy |
+7,900
| New | +$1.1M | 0.1% | 200 |
|
|
2019
Q1 | – | Sell |
-39,600
| Closed | -$2.1M | – | 651 |
|
|
2018
Q4 | $2.1M | Buy |
39,600
+14,200
| +56% | +$752K | 0.25% | 84 |
|
|
2018
Q3 | $1.52M | Buy |
+25,400
| New | +$1.52M | 0.2% | 107 |
|